Testing the Study Drug CIN-103 for Treatment of Irritable Bowel Syndrome with Predominant Diarrhea

About This Study

The purpose of this study is to learn more about the study drug CIN-103 for the treatment of irritable bowel syndrome with predominant diarrhea. We want to see if the study drug can help people have less stomach pain and more solid stools. We also want to learn more about the side effects that may be caused by the study drug.

What Activities Are a Part of this Study?

Informed Consent Review
Use of Study Treatments or Placebo
After Study Follow-Up Activities
Review of Medical History
Physical Examinations
Study Visits and Consultations
Surveys/Questionnaires
Laboratory and Imaging Tests
Specimen Sample Collection

Age & Gender

18 - 100 years old
All Genders

Language

This study enrolls English speakers only

Additional Study Information

Compensation Offered
No reimbursement offered

Study Locations

Greater Charlotte, NC

Study Topics

Stomach and Intestines

Study Locations and Contacts

Study Information
IRB Number: IRB00104211

Helpful Information

Have questions? See if your question is answered in our most common question and answers section. Need to know what something means? Browse the dictionary for explanation of common clinical study terms.